Influenza and Other Respiratory Viruses
Scope & Guideline
Elevating public health through viral research.
Introduction
Aims and Scopes
- Epidemiology of Respiratory Viruses:
Research focused on the patterns, causes, and effects of respiratory viruses, including seasonal trends and outbreak dynamics across various populations and geographical locations. - Vaccine Effectiveness and Immunology:
Investigating the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2, as well as the immunological responses elicited by these vaccines in different demographic groups. - Clinical Outcomes and Disease Burden:
Studies assessing the clinical implications of infections caused by respiratory viruses, including hospitalization rates, morbidity, mortality, and overall health impact on affected populations. - Diagnostic Methods and Innovations:
Exploration of novel diagnostic techniques and technologies for the identification and management of respiratory infections, enhancing timely clinical decisions. - Antiviral Treatments and Therapeutic Strategies:
Research into the efficacy and safety of antiviral medications and other therapeutic interventions aimed at treating infections caused by respiratory viruses. - Surveillance and Public Health:
Efforts to enhance surveillance systems for respiratory viruses, providing insights into transmission dynamics and informing public health responses.
Trending and Emerging
- COVID-19 Vaccine Efficacy and Safety:
A significant increase in studies evaluating the effectiveness and safety of various COVID-19 vaccines, reflecting ongoing global vaccination efforts and the need for continuous assessment of vaccine performance. - Long COVID and Post-Viral Syndromes:
Emerging research focusing on the long-term effects of COVID-19, including 'Long COVID' symptoms, is gaining prominence as the medical community seeks to understand and address these complex health issues. - Impact of Non-Pharmaceutical Interventions:
Studies examining the effects of non-pharmaceutical interventions (NPIs) on respiratory virus transmission patterns, particularly during the COVID-19 pandemic, are increasingly relevant for future public health strategies. - Variants of Concern and Their Epidemiology:
Research centered on the epidemiology and clinical implications of SARS-CoV-2 variants, particularly Omicron and its sublineages, has surged as understanding these variants is critical for managing future outbreaks. - Artificial Intelligence in Diagnostics:
The integration of artificial intelligence and machine learning in the diagnosis and management of respiratory viruses, enhancing speed and accuracy in clinical settings, is an emerging trend.
Declining or Waning
- Non-Influenza Respiratory Viruses:
Research specifically targeting non-influenza respiratory viruses, while still relevant, appears to be receiving comparatively less attention as the focus has shifted towards COVID-19 and its variants. - Historical Analysis of Past Pandemics:
Studies examining the historical impact of past influenza pandemics are less frequently published, likely overshadowed by contemporary issues related to COVID-19. - Animal Models for Viral Research:
While still important, the use of animal models in studying respiratory viruses may be declining as more emphasis is placed on human epidemiological studies and clinical trials. - Influenza D Virus Research:
Research on influenza D virus has waned, possibly due to its relatively low impact on human health compared to other respiratory viruses like influenza A/B and SARS-CoV-2. - Longitudinal Studies of Seasonal Variability:
Long-term studies tracking seasonal variability of respiratory viruses have decreased, as immediate responses to emerging threats like COVID-19 take precedence.
Similar Journals
Tuberculosis and Respiratory Diseases
Championing open access for global health insights.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
CURRENT OPINION IN PULMONARY MEDICINE
Connecting Experts in Pulmonary ExcellenceCurrent Opinion in Pulmonary Medicine, published by Lippincott Williams & Wilkins, is a vital resource for professionals in the field of pulmonary and respiratory medicine. With a robust ISSN of 1070-5287 and an E-ISSN of 1531-6971, this journal has been converging insightful research and expert opinions since 1995. It currently holds a respectable Q2 category ranking in the 2023 Scopus rankings for pulmonary and respiratory medicine, placing it within the 74th percentile of its field. The journal provides an excellent platform for clinicians, researchers, and students to keep abreast of the latest developments, trends, and therapeutic advances, ensuring that it remains an essential component of ongoing education and scholarship in respiratory health. While not open access, the journal offers various subscription options to facilitate access to cutting-edge pulmonary research. Located in Philadelphia, Pennsylvania, Current Opinion in Pulmonary Medicine continues to shape the future of respiratory medicine through its commitment to high-quality content and academic excellence.
BMJ Open Respiratory Research
Connecting researchers and practitioners for impactful respiratory solutions.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Expert Review of Respiratory Medicine
Connecting Research to Practice in Pulmonary MedicineExpert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.
Thoracic Research and Practice
Pioneering Discoveries in Pulmonary and Respiratory MedicineThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
RESPIRATORY MEDICINE
Innovating Solutions for Respiratory ChallengesRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
INTERVIROLOGY
Exploring the frontiers of infectious disease science.INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.
THORAX
Pioneering insights in pulmonary health.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Respiratory Medicine and Research
Connecting research to real-world respiratory solutions.Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.
BMC Pulmonary Medicine
Connecting researchers and practitioners for impactful insights.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.